Similar Companies:

SPRIN Technologies

Italy

Privately Held

SPRIN develops, produces and distributes worldwide Immobilised Enzymes and Polymers for Enzyme Immobilisation to be applied in various industrial production processes. SPRIN offers a wide portfolio of SPRINzymes: Immobilised Enzymes on polymeric beads conceived for industrial application, offering stability, recyclability, activity and cost effectiveness. SPRINzymes are used for the production of cosmetics, drugs, fine chemicals, bio-fuels and food ingredients. SPRIN can provide both custom made and catalogue ready Immobilised Enzymes, as well as provide services for bio-catalysed process development and immobilised enzyme optimisation. We can find the right enzyme for your process and transform it into an industrially sustainable biocatalyst.

AVRO Life Science

Canada

Privately Held

Avro Life Science’s pipeline is focused on improving patient outcomes and quality of life by delivering high-value medication through the skin. Avro’s passive topical delivery platform serves to redefine the skin’s potential as a therapeutic vector, enabling the systemic delivery of small molecules and peptides, and the localized delivery of larger, complex therapeutics, including proteins, antibodies, nucleic acids, CRISPR, and more into the skin, without the use of microneedles or other invasive technology. Avro’s vision is to enhance the delivery of a range of existing therapeutics, while unlocking the potential of the next generation of dermal therapies and novel modalities in the same way that lipid nanoparticle technology unlocked the potential of mRNA vaccines. Our systemic drug delivery portfolio focuses on translating non-orally available small molecules and peptides (often delivered subcutaneously/intravenously) into 1-7 day use transdermal patches (dose-dependent). Current programs in PD and ALS address neurologically and/or motor-compromised elderly populations which are underserved by today’s invasive and inaccessible delivery methods. Our topical drug delivery portfolio serves to enable the in-situ dermal delivery of novel therapeutic modalities like nucleic acid therapeutics (ASOs, siRNAs, mRNAs, CRISPR-RNPs) for gene editing and therapy in the skin, with curative intent. Our topical platform also enables the targeted delivery of biologics like proteins and antibodies for localized therapeutic effects with reduced side effect profiles and higher site-specific efficacy. Our NCE portfolio utilises PEGylated small molecules and novel targets (TrkA) to address some of the most prevalent inflammatory skin conditions such aspsoriasis, and atopic dermatitis.

Provision Analytics

Canada

Privately Held

Provision Analytics has developed a traceability and reporting software for the food value chain.

coramaze technologies

Germany

Privately Held

coramaze technologies GmbH, a German company founded and based in Essen as a spin-off from the Western German Heart Center, is developing an innovative medical device for the minimally invasive treatment of one of the most common structural heart valve diseases, mitral regurgitation.

Nimbus Discovery

USA

Privately Held

Nimbus Discovery is leveraging an asset-centric, virtual drug discovery model that exploits a breakthrough in silico technology.

Lophius Biosciences

Germany

Privately Held

Lophius develops products for T-cell diagnostic of autoimmune and acute infectious diseases based on their proprietary T cell technologies, initially focused on tuberculose and EBV/CMV infections.

Develops innovative solutions for algae biomass utilization, transforming it into valuable products for nutrition, cosmetics, and pharmaceutical industries.
VentureRadar Research / Company Website

The leading development partner for utilization of algae biomass. Algae are used for nutrition, cosmetics or pharmaceuticals.
VentureRadar Research / Company Website

Associated sectors:
Healthtech; Life Sciences; n; a;